microRNA‐221 rescues the loss of dopaminergic neurons in a mouse model of Parkinson's disease
Brain and Behavior · 2023-03 · 13 (3)
DOI: 10.1002/brb3.2921 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, online erschienen am 16.02.2023. Verfasst von Yufang Yao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department 7 of Neurology, Cangzhou Central Hospital, Cangzhou, Hebei, China. Hauptthemen laut MEDLINE: Parkinson Disease, MicroRNAs. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Self-funded Project of Cangzhou Key Plan in 2020.
Abstract (Originalsprache)
Background
Parkinson's disease (PD) is one of the most common systemic neurodegenerative diseases and is related to the loss of dopaminergic neurons in the substantia nigra. Several studies verified that microRNA (miRNAs) targeting the Bim/Bax/caspase‐3 signaling axis is involved in the apoptosis of dopaminergic neurons in substantia nigra. In this study, we aimed to explore the role of miR‐221 in PD.
Methods
To examine the function of miR‐221 in vivo, we used a well‐established 6‐OHDA‐induced PD mouse model. Then we conducted adenovirus‐mediated miR‐221 overexpression in the PD mice.
Results
Our results showed that miR‐221 overexpression improved motor behavior of the PD mice. We demonstrated that overexpression of miR‐221 reduced the loss of dopaminergic neurons in the substantia nigra striatum by promoting their antioxidative and antiapoptosis capacities. Mechanistically, miR‐221 targets Bim, thus inhibiting Bim and Bax caspase‐3 mediated apoptosis signaling pathways.
Conclusion
Our findings suggest miR‐221 participates in the pathological process of PD and might be a potential drug target and provide new insight into PD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department 7 of Neurology, Cangzhou Central Hospital, Cangzhou, Hebei, China.
- College of Mechanical and Electrical Engineering, Cangzhou Normal University, Cangzhou, Hebei, China.
- Department 4 of Neurology, Cangzhou Central Hospital, Cangzhou, Hebei, China.
- Department 1 of Traditional Chinese Medicine, Cangzhou Central Hospital, Cangzhou, Hebei, China.
ORCID-Profile: Yufang Yao
Förderung
- Self-funded Project of Cangzhou Key Plan in 2020
Zitieren
APA
Yao, Y., Zhao, Z., Zhang, F., Miao, N., Wang, N., Xu, X., & Yang, C. (2023). microRNA‐221 rescues the loss of dopaminergic neurons in a mouse model of Parkinson's disease. Brain and Behavior, 13(3). https://doi.org/10.1002/brb3.2921
Vancouver
Yao Y, Zhao Z, Zhang F, Miao N, Wang N, Xu X, et al. microRNA‐221 rescues the loss of dopaminergic neurons in a mouse model of Parkinson's disease. Brain and Behavior. 2023;13(3). doi:10.1002/brb3.2921
BibTeX
@article{Yao2023,
author = {Yao, Yufang and Zhao, Zhiyue and Zhang, Fubo and Miao, Na and Wang, Nan and Xu, Xin and Yang, Chaoping},
title = {microRNA‐221 rescues the loss of dopaminergic neurons in a mouse model of Parkinson's disease},
journal = {Brain and Behavior},
year = {2023},
volume = {13},
number = {3},
doi = {10.1002/brb3.2921}
}
EUVIMED